Cite
Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis.
MLA
Lin, Chien-Yu, et al. “Cellular Protein Markers, Therapeutics, and Drug Delivery Strategies in the Treatment of Diabetes-Associated Liver Fibrosis.” Advanced Drug Delivery Reviews, vol. 174, July 2021, pp. 127–39. EBSCOhost, https://doi.org/10.1016/j.addr.2021.04.008.
APA
Lin, C.-Y., Adhikary, P., & Cheng, K. (2021). Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Advanced Drug Delivery Reviews, 174, 127–139. https://doi.org/10.1016/j.addr.2021.04.008
Chicago
Lin, Chien-Yu, Pratik Adhikary, and Kun Cheng. 2021. “Cellular Protein Markers, Therapeutics, and Drug Delivery Strategies in the Treatment of Diabetes-Associated Liver Fibrosis.” Advanced Drug Delivery Reviews 174 (July): 127–39. doi:10.1016/j.addr.2021.04.008.